Company Statement: Roche intends to commence tender offer to acquire all shares of Genentech for US$ 86.50 per share in cash
Extract: Roche announced today that it intends to commence a cash tender offer for all outstanding publicly-held shares of Genentech at US$ 86.50 per share. Roche, which currently owns 55.8% of...To view the full article, register now.
Already a subscriber? Click here to view full article